RESPeRATE
RESPeRATE is a medical device with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Peripheral Microcirculation Hemodynamics Following Various Changes Based on Noninvasive Thermography
Respiratory Biofeedback Device and Reduction of Dental Anxiety Associated With Local Anesthesia in Children
Breathe: Slow Paced Breathing to Lower Blood Pressure
RCT of Effects of Device-guided Breathing on Ambulatory BP
Slow Paced-Respiration Intervention to Reduce Incontinence Trial (SPIRIT)
Clinical Trials (7)
Evaluation of Peripheral Microcirculation Hemodynamics Following Various Changes Based on Noninvasive Thermography
Respiratory Biofeedback Device and Reduction of Dental Anxiety Associated With Local Anesthesia in Children
Breathe: Slow Paced Breathing to Lower Blood Pressure
RCT of Effects of Device-guided Breathing on Ambulatory BP
Slow Paced-Respiration Intervention to Reduce Incontinence Trial (SPIRIT)
Device-guided Breathing Exercises on Blood Pressure in Diabetic Patients
The Effects of Device-guided Breathing Exercises on Blood Pressure in Patients With Hypertension
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7